Skip to main content
Erik Goluboff, MD, Urology, New York, NY

Erik T Goluboff MD MBA, FACS

Surgical Oncology


Global Clinical Head, Imfinzi GU (bladder cancer), Women’s Cancers, Tumor Agnostic, Life Cycle, Clinical Safety

Join to View Full Profile
  • 430 East 29th StreetNew York, NY 10016

  • Phone+1 914-953-7656

Dr. Goluboff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Urology, 1992 - 1996
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 1991 - 1992
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Surgery, 1990 - 1991
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1990

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1991 - 2025
  • FL State Medical License
    FL State Medical License 2017 - 2019
  • Urology
    American Board of Urology Urology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)
    Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)January 10th, 2025

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: